PatientsVille.com Logo

PatientsVille

Temesta Side Effects

Common Temesta Side Effects


The most commonly reported Temesta side effects (click to view or check a box to report):

Fall (19)
Confusional State (12)
Disorientation (8)
Condition Aggravated (7)
Somnolence (7)
Agitation (6)
Orthostatic Hypotension (6)
Dehydration (6)
Delirium (5)
Diarrhoea (5)
Gait Disturbance (5)
Intentional Overdose (5)
Hallucination, Visual (5)
Suicide Attempt (5)
Anxiety (5)
Renal Failure (5)
Pyrexia (5)
Coordination Abnormal (5)
Loss Of Consciousness (5)
Hyponatraemia (4)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Temesta Side Effects Reported to FDA

The following Temesta reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Temesta on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Pulmonary Embolism, Depressed Level Of Consciousness, Tachycardia, Cardiac Disorder
This is a report of a 18-year-old male patient (weight: NA) from AT, suffering from the following symptoms/conditions: NA, who was treated with Temesta (dosage: Unk, start time: Aug 06, 2013), combined with:
  • Pantoloc (40 Mg, 1x/day)
  • Haldol (Unk)
  • Zyprexa (10 Mg, 1x/day)
  • Trittico (150 Mg, 1x/day)
  • Dexdor
  • Dormicum For Injection (Unk)
  • Nubain (Unk)
  • Hyoscine (Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Pulmonary Embolism
  • Depressed Level Of Consciousness
  • Tachycardia
  • Cardiac Disorder
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Temesta treatment in male patients, resulting in pulmonary embolism side effect. The patient was hospitalized.

Inappropriate Antidiuretic Hormone Secretion, Hyponatraemia, Fall
This report suggests a potential Temesta Inappropriate Antidiuretic Hormone Secretion, Hyponatraemia, Fall side effect(s) that can have serious consequences. A 93-year-old female patient (weight: NA) from CH was diagnosed with the following symptoms/conditions: NA and used Temesta (dosage: 1 Mg, 1x/day) starting Aug 02, 2013. Soon after starting Temesta the patient began experiencing various side effects, including:
  • Inappropriate Antidiuretic Hormone Secretion
  • Hyponatraemia
  • Fall
Drugs used concurrently:
  • Pantoprazole (40 Mg, 1x/day)
  • Rabeprazole Sodium (10 Mg, 1x/day)
  • Spasmo Urgenin Neo (1 Df, Unk)
  • Xalatan (Unk)
  • Xarelto (15 Mg, Unk)
The patient was hospitalized. Although Temesta demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as inappropriate antidiuretic hormone secretion, may still occur.

Off Label Use, Nausea, Lacrimation Increased, Visual Acuity Reduced, Dizziness
This Off Label Use, Nausea, Lacrimation Increased, Visual Acuity Reduced, Dizziness problem was reported by a consumer or non-health professional from CH. A 30-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Temesta (dosage: 2.5 Mg, 4x/day). The following drugs were being taken at the same time:
  • Lyrica (Unk)
  • Zoloft
  • Sirdalud
  • Novalgin
When commencing Temesta, the patient experienced the following unwanted symptoms/side effects:
  • Off Label Use
  • Nausea
  • Lacrimation Increased
  • Visual Acuity Reduced
  • Dizziness
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as off label use, may become evident only after a product is in use by the general population.

Dry Eye, Culture Urine Positive, Sjogren's Syndrome, Arthralgia, Rash, Xerophthalmia, Blood Pressure Systolic Increased, Dry Mouth, Fatigue
This is a report of a 71-year-old female patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: NA and was treated with Temesta (lorazepam) (lorazepam) (dosage: NA) starting Jan 27, 2010. Concurrently used drugs:
  • Nexium
  • Detensiel (bisoprolol) (bisoprolol)
  • Stablon (tianeptine Sodium) (tianeptine Sodium)
  • Zocor
  • Axeler (olmesartan Medoxomil, Amlodipine Besilate) (tablet) (olmesarta (20/5mg, Oral)
  • Dafalgan (paracetamol) (paracetamol)
Soon after that, the consumer experienced the following side effects:
  • Dry Eye
  • Culture Urine Positive
  • Sjogren's Syndrome
  • Arthralgia
  • Rash
  • Xerophthalmia
  • Blood Pressure Systolic Increased
  • Dry Mouth
  • Fatigue
The patient was hospitalized. This opens a possibility that Temesta (lorazepam) (lorazepam) treatment could cause the above reactions, including dry eye, and some female subjects may be more susceptible.


Diplopia, Headache, Vision Blurred, Ocular Myasthenia
A 70-year-old male patient (weight: NA) from FRANCE with the following symptoms/conditions: NA started Temesta /00273201/ treatment (dosage: NA) on Jan 01, 1995. Soon after starting Temesta /00273201/ treatment, the subject experienced various side effects, including:
  • Diplopia
  • Headache
  • Vision Blurred
  • Ocular Myasthenia
Concurrently used drugs:
  • Enbrel (50 Mg, Weekly)
  • Lansoprazole (Unk)
  • Irbesartan
  • Tenordate (Unk)
  • Plavix (Unk)
  • Mestinon (1 Tablet Three Times Daily.)
  • Sulfasalazine (Unk)
  • Metformin Hcl (Unk)
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Temesta /00273201/.

Pancreatitis Acute, Off Label Use
A 66-year-old female patient from DENMARK (weight: NA) experienced symptoms, such as: NA and was treated with Temesta (lorazepam) (tablets) (lorazepam)(dosage: NA). The treatment was initiated on Jan 01, 2007. After that a consumer reported the following side effect(s):
  • Pancreatitis Acute
  • Off Label Use
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Temesta (lorazepam) (tablets) (lorazepam) efficacy:
  • Creon (pancreatin) (pancreatin)
  • Pantozol (pantoprazole Sodium Sesquihydrate) (tablets) (pantoprazole S
  • Truxal Dragees (chlorprothixene Hydrochloride) (tablets) (chlorprothix
  • Stilnox (zolpidem Tartrate) (tablets) (zolpidem Tartrate)
  • Remeron
  • Novothyral (novothyral) (tablets) (novothyral)
  • Escitalopram Oxalate (15 Mg (15 Mg, 1 In 1 D), Oral)
  • Novalgin (metamizole Sodium Monohydrate) (metamizole Sodium Monohydrat
The patient was hospitalized.

Asphyxia, Completed Suicide, Hyperhidrosis
In this report, Temesta (lorazepam) (lorazepam) was administered for the following condition: NA.A 53-year-old male consumer from DENMARK (weight: NA) started Temesta (lorazepam) (lorazepam) treatment (dosage: NA) on Jul 01, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Asphyxia
  • Completed Suicide
  • Hyperhidrosis
A possible interaction with other drugs could have contributed to this reaction:
  • Escitalopram (10 Mg (10 Mg,1 In 1 D) ; 10 Mg (10 Mg,1 In 1 D))
  • Escitalopram (10 Mg (10 Mg,1 In 1 D) ; 10 Mg (10 Mg,1 In 1 D))
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Temesta (lorazepam) (lorazepam) treatment could be related to the listed above side effect(s).

Convulsion, Electrocardiogram Qt Prolonged, Fall, Torsade De Pointes
This is a report of the following Temesta /00273201/ side effect(s):
  • Convulsion
  • Electrocardiogram Qt Prolonged
  • Fall
  • Torsade De Pointes
A 66-year-old male patient from SWITZERLAND (weight: NA) presented with the following condition: NA and received a treatment with Temesta /00273201/ (dosage: NA) starting: Jul 11, 2011.The following concurrently used drugs could have generated interactions:
  • Remeron
  • Levothyroxine Sodium
  • Seroquel (37.5 Mg;qd;po)
  • Citalopram Hydrobromide (40 Mg;qd;po)
  • Losartan Potassium
  • Pantoprazole Sodium
The patient was hospitalized.This report suggests that a Temesta /00273201/ treatment could be associated with the listed above side effect(s).

Intentional Overdose, Metabolic Acidosis, Continuous Haemodiafiltration, Vomiting, Suicide Attempt, Blood Lactic Acid Increased
This Temesta (lorazepam)(lorazepam) report was submitted by a 20-year-old female consumer from DENMARK (weight: NA). The patient was diagnosed with: NA and Temesta (lorazepam)(lorazepam) was administered (dosage: NA) starting: May 10, 2011. The consumer developed a set of symptoms:
  • Intentional Overdose
  • Metabolic Acidosis
  • Continuous Haemodiafiltration
  • Vomiting
  • Suicide Attempt
  • Blood Lactic Acid Increased
Other drugs used simultaneously:
  • Escitalopram (20 Mg (20 Mg, 1 In 1 D), Oral)
  • Solian (amisulpride)(amisulpride)
  • Janumet (Overdose: 180 Tabs Once, Oral)
The patient was hospitalized.Those unexpected symptoms could be linked to a Temesta (lorazepam)(lorazepam) treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Weight Increased, Muscle Twitching, Overdose, Withdrawal Syndrome, Feeling Abnormal
This is a report of a possible correlation between Temesta Expidet (astemizole)(astemizole) use and the following symptoms/side effect(s):
  • Weight Increased
  • Muscle Twitching
  • Overdose
  • Withdrawal Syndrome
  • Feeling Abnormal
which could contribute to an assessment of Temesta Expidet (astemizole)(astemizole) risk profile.A 33-year-old male consumer from DENMARK (weight: NA) was suffering from NA and was treated with Temesta Expidet (astemizole)(astemizole) (dosage: NA) starting Mar 01, 2007.Other concurrent medications:
  • Escitalopram Oxalate


Breast Pain, Galactorrhoea, Breast Swelling
A 21-year-old female patient from DENMARK (weight: NA) presented with the following symptoms: NA and after a treatment with Temesta (lorazepam) (tablets) (lorazepam) (dosage: NA) experienced the following side effect(s):
  • Breast Pain
  • Galactorrhoea
  • Breast Swelling
The treatment was started on Jun 03, 2010. Temesta (lorazepam) (tablets) (lorazepam) was used in combination with the following drugs:
  • Escitalopram (20 Mg (20 Mg, 1 In 1 D), Oral)
  • Escitalopram (10 Mg (10 Mg, 1 In 1 D), Oral)
  • Depakine (valproic Acid)(tablets) (valproic Acid)
  • Seroquel Xr (350 Mg (350 Mg, 1 In 1 D), 100 Mg (100 Mg,1 In 1 D))
  • Seroquel Xr (350 Mg (350 Mg, 1 In 1 D), 100 Mg (100 Mg,1 In 1 D))
The patient was hospitalized.This report could alert potential Temesta (lorazepam) (tablets) (lorazepam) consumers.

Gastric Polyps
In this report, a 56-year-old female patient from FINLAND (weight: NA) was affected by a possible Temesta side effect.The patient was diagnosed with NA. After a treatment with Temesta (dosage: 1 Mg, (1-3 Tablet Per Day), start date: NS), the patient experienced the following side effect(s):
  • Gastric Polyps
The following simultaneously used drugs could have led to this reaction:
  • Diurex (1 Df, 1x/day)
  • Activelle (1 Df, 1x/day)
  • Rivatril (0.5 Mg, 4x/day)
  • Pantoprazole (40 Mg, (1-2 Tablet Per Day))
  • Sepram (20 Mg, 0.5 Dose Form)
The findings here stress that side effects should be taken into consideration when evaluating a Temesta treatment.

Pyelonephritis
This is a report of a male patient from BELGIUM (weight: NA), who used Temesta (dosage: 1mg As Required) for a treatment of nausea. After starting a treatment on Dec 28, 2010, the patient experienced the following side effect(s):
  • Pyelonephritis
The following drugs could possibly have interacted with the Temesta treatment
  • Lapatinib (1250mg Per Day)
  • Gemcitabine (1600mg Per Day)
  • Cisplatin (53.3mg Per Day)
  • Pantoprazole Sodium (40mg Per Day)
  • Primperan Tab (30mg As Required)
The patient was hospitalized.Taken together, these observations suggest that a Temesta treatment could be related to side effect(s), such as Pyelonephritis.

Apnoea, Tachycardia, Pyrexia, Respiratory Disorder, Respiratory Rate Increased, Dysphagia, Muscle Spasticity, Eosinophilic Myocarditis, Cardio-respiratory Arrest
This apnoea side effect was reported by a consumer or non-health professional from SWITZERLAND. A 18-year-old female patient (weight:NA) experienced the following symptoms/conditions: encephalitis. The patient was prescribed Temesta (dosage: 16 Mg, Daily), which was started on NS. Concurrently used drugs:
  • Benzodiazepines (5 To 10 Mg Daily Dose)
  • Leponex (6.25 Mg, Daily)
When starting to take Temesta the consumer reported the following symptoms:
  • Apnoea
  • Tachycardia
  • Pyrexia
  • Respiratory Disorder
  • Respiratory Rate Increased
  • Dysphagia
  • Muscle Spasticity
  • Eosinophilic Myocarditis
  • Cardio-respiratory Arrest
These side effects may potentially be related to Temesta.

Haemoglobin Decreased, Epistaxis, Renal Failure, Vomiting
This is a Temesta side effect report of a female patient (weight:NA) from FRANCE, suffering from the following symptoms/conditions: NA, who was treated with Temesta (dosage:5 Mg, start time: Mar 03, 2011), combined with:
  • Venofer
  • Pradaxa (110 Mg)
  • Naropin
  • Vancomycine
  • Quixil
  • Morphine
  • Pradaxa (150 Mg)
  • Zophren
, and developed a serious reaction and a haemoglobin decreased side effect. The patient presented with:
  • Haemoglobin Decreased
  • Epistaxis
  • Renal Failure
  • Vomiting
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Temesta treatment in female patients suffering from NA, resulting in haemoglobin decreased.

Angiomyolipoma, Kidney Infection, Nephrolithiasis
This report suggests a potential Temesta angiomyolipoma side effect(s) that can have serious consequences. A 58-year-old female patient from FRANCE (weight:NA) was diagnosed with the following health condition(s): insomnia and used Temesta (dosage: NA) starting Sep 26, 2008. Soon after starting Temesta the patient began experiencing various side effects, including:
  • Angiomyolipoma
  • Kidney Infection
  • Nephrolithiasis
Drugs used concurrently:
  • Oxybutynin
  • Stilnox
  • Atenolol
  • Minirin
  • Tysabri
The patient was hospitalized. Although Temesta demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as angiomyolipoma, may still occur.

Varices Oesophageal, Oesophageal Varices Haemorrhage, Gastrointestinal Haemorrhage
This varices oesophageal problem was reported by a health professional from FRANCE. A 79-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Feb 02, 2010 a consumer started treatment with Temesta (dosage: NA). The following drugs/medications were being taken at the same time:
  • Allopurinol
  • Forlax
  • Kerlone
  • Zoloft
  • Warfarin
  • Inipomp (40 Mg, 1x/day)
When commencing Temesta, the patient experienced the following unwanted symptoms /side effects:
  • Varices Oesophageal
  • Oesophageal Varices Haemorrhage
  • Gastrointestinal Haemorrhage
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as varices oesophageal, may become evident only after a product is in use by the general population.

Gastric Polyps
This is a Temesta side effect report of a 56-year-old female patient (weight: NA) from FINLAND. The patient developed the following symptoms/conditions: NA and was treated with Temesta (dosage: 1 Mg, (1-3 Tablet Per Day)) starting NS. Concurrently used drugs:
  • Somac (40 Mg, (1-2 Tablet Per Day))
  • Diurex (1 Df, 1x/day)
  • Activelle (1 Df, 1x/day)
  • Sepram (20 Mg, 0.5 Dose Form)
  • Rivatril (0.5 Mg, 4x/day)
Soon after that, the consumer experienced the following of symptoms:
  • Gastric Polyps
This opens a possibility that Temesta could cause gastric polyps and that some female patients may be more susceptible.

Confusional State, Delirium, Insomnia, Psychomotor Hyperactivity, Hallucination
A 47-year-old female patient (weight: NA) from FRANCE with the following symptoms: confusional state started Temesta treatment (dosage: NA) on Dec 10, 2010. Soon after starting Temesta treatment, the consumer experienced several side effects, including:
  • Confusional State
  • Delirium
  • Insomnia
  • Psychomotor Hyperactivity
  • Hallucination
. Concurrently used drugs:
  • Depakote
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Temesta side effects, such as confusional state.

Chest Discomfort, Flushing, Vertigo, Inflammatory Pain, Myalgia, Diarrhoea, Nausea, Hot Flush, Asthenia
This chest discomfort side effect was reported by a physician from FRANCE. A 43-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Temesta (dosage: NA), which was started on NS. Concurrently used drugs:
  • Methotrexate
  • Remicade
  • Sertraline Hydrochloride (Associated With Infliximab)
  • Isoniazid (Planned To Be Discontinued 09-jan-2011)
  • Remicade
  • Prednisone
  • Remicade
  • Remicade
.When starting to take Temesta the consumer reported symptoms, such as:
  • Chest Discomfort
  • Flushing
  • Vertigo
  • Inflammatory Pain
  • Myalgia
  • Diarrhoea
  • Nausea
  • Hot Flush
  • Asthenia
These side effects may potentially be related to Temesta.

Sepsis, Cardiomyopathy, Pyrexia, Dehydration, Dyspnoea, Malaise, Acute Prerenal Failure, Diarrhoea
This is a report of a female patient (weight: NA) from AUSTRIA, suffering from the following symptoms/conditions: NA, who was treated with Temesta (dosage: NA, start time: Feb 08, 2011), combined with:
  • Bondronat
  • Afinitor (10 Mg, Qd)
  • Comparator Exemestane (25 Mg, Qd)
  • Parkemed
  • Afinitor
and developed a serious reaction and side effect(s). The consumer presented with:
  • Sepsis
  • Cardiomyopathy
  • Pyrexia
  • Dehydration
  • Dyspnoea
  • Malaise
  • Acute Prerenal Failure
  • Diarrhoea
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Temesta treatment in female patients, resulting in sepsis side effect. The patient was hospitalized.

Abortion Spontaneous
This report suggests a potential Temesta Abortion Spontaneous side effect(s) that can have serious consequences. A 35-year-old female patient (weight: NA) from SWITZERLAND was diagnosed with the following symptoms/conditions: mental disorder and used Temesta (dosage: NA) starting NS. Soon after starting Temesta the patient began experiencing various side effects, including:
  • Abortion Spontaneous
Drugs used concurrently:
  • Zoloft (Unk)
  • Xanax (Unk)
Although Temesta demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as abortion spontaneous, may still occur.

Splint Application, Surgery, Concomitant Disease Progression, Gangrene, Extremity Necrosis, Finger Amputation, Polyarthritis, Carotid Artery Stenosis
This Splint Application, Surgery, Concomitant Disease Progression, Gangrene, Extremity Necrosis, Finger Amputation, Polyarthritis, Carotid Artery Stenosis problem was reported by a physician from AUSTRIA. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Dec 29, 2006 this consumer started treatment with Temesta (dosage: NA). The following drugs were being taken at the same time:
  • Pantoloc
  • Maxi-kalz
  • Aspirin
  • Nicorette
  • Fragmin
  • Mexilen
  • Citalopram
  • Atorvastatin
When commencing Temesta, the patient experienced the following unwanted symptoms/side effects:
  • Splint Application
  • Surgery
  • Concomitant Disease Progression
  • Gangrene
  • Extremity Necrosis
  • Finger Amputation
  • Polyarthritis
  • Carotid Artery Stenosis
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as splint application, may become evident only after a product is in use by the general population.

Cardiomyopathy, Pyrexia, Dehydration, Dyspnoea, Thrombophlebitis, Renal Impairment, Sepsis, Diarrhoea
This is a report of a female patient (weight: NA) from AUSTRIA. The patient developed the following symptoms/conditions: NA and was treated with Temesta (dosage: NA) starting Nov 04, 2010. Concurrently used drugs:
  • Afinitor (10 Mg, Qd)
  • Parkemed
  • Afinitor
  • Comparator Exemestane (25 Mg, Qd)
  • Bondronat
Soon after that, the consumer experienced the following side effects:
  • Cardiomyopathy
  • Pyrexia
  • Dehydration
  • Dyspnoea
  • Thrombophlebitis
  • Renal Impairment
  • Sepsis
  • Diarrhoea
The patient was hospitalized. This opens a possibility that Temesta treatment could cause the above reactions, including cardiomyopathy, and some female subjects may be more susceptible.

Interstitial Lung Disease, Po2 Decreased, Bronchiolitis, Syncope, Leukocytosis, Asthma, Dyspnoea, Dysphonia, Autoimmune Thyroiditis
A 40-year-old female patient (weight: NA) from FINLAND with the following symptoms/conditions: mental disorder,asthma started Temesta treatment (dosage: Unk) on Aug 20, 2009. Soon after starting Temesta treatment, the subject experienced various side effects, including:
  • Interstitial Lung Disease
  • Po2 Decreased
  • Bronchiolitis
  • Syncope
  • Leukocytosis
  • Asthma
  • Dyspnoea
  • Dysphonia
  • Autoimmune Thyroiditis
Concurrently used drugs:
  • Seretide (Unk)
  • Leponex (150 Mg, Qd)
  • Singulair (Unk)
  • Prednisolone (2.5 Mg, Qd)
  • Lito (300 Mg, Unk)
This finding indicates that some female patients could be more vulnerable to Temesta.

1 of 6 



Top 10 Temesta Side Effects for Women

Women Side EffectsReports
Fall 12
Dehydration 6
Somnolence 6
Condition Aggravated 5
Confusional State 5
Pyrexia 5
Agitation 4
Bladder Tamponade 4
Delirium 4
Diarrhoea 4

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Temesta Side Effects

    Did You Have a Temesta Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Temesta for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Temesta Safety Alerts, Active Ingredients, Usage Information

    More About Temesta

    Side Effects reported to FDA: 138

    Temesta safety alerts: No

    Reported deaths: 15

    Reported hospitalizations: 86

    Latest Temesta clinical trials